359 related articles for article (PubMed ID: 30254377)
1. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model.
Flores J; Noël A; Foveau B; Lynham J; Lecrux C; LeBlanc AC
Nat Commun; 2018 Sep; 9(1):3916. PubMed ID: 30254377
[TBL] [Abstract][Full Text] [Related]
2. Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging.
Flores J; Noël A; Foveau B; Beauchet O; LeBlanc AC
Nat Commun; 2020 Sep; 11(1):4571. PubMed ID: 32917871
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment.
Flores J; Noël A; Fillion ML; LeBlanc AC
Cell Death Differ; 2022 Mar; 29(3):657-669. PubMed ID: 34625662
[TBL] [Abstract][Full Text] [Related]
4. Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer's Disease Model Mice.
Ramasamy VS; Samidurai M; Park HJ; Wang M; Park RY; Yu SY; Kang HK; Hong S; Choi WS; Lee YY; Kim HS; Jo J
Mol Neurobiol; 2020 Jan; 57(1):315-330. PubMed ID: 31332763
[TBL] [Abstract][Full Text] [Related]
5. Tartary buckwheat improves cognition and memory function in an in vivo amyloid-β-induced Alzheimer model.
Choi JY; Cho EJ; Lee HS; Lee JM; Yoon YH; Lee S
Food Chem Toxicol; 2013 Mar; 53():105-11. PubMed ID: 23219778
[TBL] [Abstract][Full Text] [Related]
6. Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
Carnevale D; Mascio G; D'Andrea I; Fardella V; Bell RD; Branchi I; Pallante F; Zlokovic B; Yan SS; Lembo G
Hypertension; 2012 Jul; 60(1):188-97. PubMed ID: 22615109
[TBL] [Abstract][Full Text] [Related]
7. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
9. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
10. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
11. Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.
Ali MR; Abo-Youssef AM; Messiha BA; Khattab MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):637-56. PubMed ID: 27026404
[TBL] [Abstract][Full Text] [Related]
12. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
13. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
14. Autophagy impairment by caspase-1-dependent inflammation mediates memory loss in response to β-Amyloid peptide accumulation.
Álvarez-Arellano L; Pedraza-Escalona M; Blanco-Ayala T; Camacho-Concha N; Cortés-Mendoza J; Pérez-Martínez L; Pedraza-Alva G
J Neurosci Res; 2018 Feb; 96(2):234-246. PubMed ID: 28801921
[TBL] [Abstract][Full Text] [Related]
15. Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice.
Flores J; Fillion ML; LeBlanc AC
Cell Death Dis; 2022 Oct; 13(10):864. PubMed ID: 36220815
[TBL] [Abstract][Full Text] [Related]
16. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
17. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
[TBL] [Abstract][Full Text] [Related]
18. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
[TBL] [Abstract][Full Text] [Related]
19. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
20. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
